Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2012
05/30/2012CN101732653B Medicament for curing senile cervical and lumbar vertebra diseases
05/30/2012CN101732440B Raspberry extract and raspberry element obtain by separation thereof and application thereof
05/30/2012CN101711768B Application of diosmin in manufacturing medicaments
05/30/2012CN101569674B Chinese medicament for expelling rheumatism and removing obstruction in channels to relieve pain
05/30/2012CN101559218B Composition with function of increasing bone density
05/30/2012CN101550119B Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing same
05/30/2012CN101537170B Compound for preventing osteoporosis and osteoarthrosis
05/30/2012CN101485722B Medicament composition containing drynaria and salvia root, and use thereof
05/30/2012CN101474271B Medicament for treating uarthritis
05/30/2012CN101415678B Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists
05/30/2012CN101402675B Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides
05/30/2012CN101385798B Wind dispelling and pain relieving paste
05/30/2012CN101283796B Health products for osteoporosis and cardio-cerebrovascular disease using walnut oil as matrix
05/30/2012CN101264120B Modern Chinese medicine decoction pieces, barrenwort flavonol glycosides decoction pieces and preparation thereof
05/30/2012CN101254282B Combination for curing cervical vertebra disease
05/30/2012CN101028353B Keeled cervical vertebrae medicine and its production
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188272 Fused heterocyclic compounds useful as kinase modulators
05/29/2012US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
05/29/2012US8188219 Cyclic peptide for use in diagnosis, prevention and treatment of bone disorders
05/29/2012US8188113 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies
05/29/2012US8188074 Biologically active methylene blue derivatives
05/29/2012US8188066 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
05/29/2012US8188056 Utilizing nucleic acid expression constructs that are delivered into a subject and express stable therapeutic proteins in vivo
05/29/2012CA2684582C N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical compositioncomprising the same
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2495350C Use of lck inhibitor for treatment of immunologic diseases
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2458611C Aminobenzophenones as interleukin 1-beta and tumour necrosis factor-alpha inhibitors
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/29/2012CA2377957C Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
05/29/2012CA2343579C Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
05/29/2012CA2220777C Novel heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/24/2012WO2012068540A2 Neutralizing anti-ccl20 antibodies
05/24/2012WO2012068470A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
05/24/2012WO2012068209A2 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
05/24/2012WO2012068204A1 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012WO2012066478A1 Quinolinone derivatives
05/24/2012WO2012066061A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
05/24/2012WO2012037043A8 Treatment of autoimmune inflammation using mir-155
05/24/2012WO2012018499A3 Specific regulation of cytokine levels by hdac6 inhibitors
05/24/2012US20120130435 Compositions and methods for arthrodetic procedures
05/24/2012US20120130350 Detection and treatment of autoimmune disorders
05/24/2012US20120129948 Medical implant producing wear particles with benign body response
05/24/2012US20120129930 Ketone compounds and compositions for cholesterol management and related uses
05/24/2012US20120129926 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/24/2012US20120129914 Organic compositions to treat hsf1-related diseases
05/24/2012US20120129906 Modulators of s1p receptors
05/24/2012US20120129903 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetate, and uses thereof
05/24/2012US20120129897 Bis heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
05/24/2012US20120129878 Tablet
05/24/2012US20120129873 Inhibitors of bruton's tyrosine kinase
05/24/2012US20120129872 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129870 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
05/24/2012US20120129851 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
05/24/2012US20120129843 Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129842 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
05/24/2012US20120129829 Novel indole modulators of s1p receptors
05/24/2012US20120129828 S1p1 receptor agonists and use thereof
05/24/2012US20120129814 Novel phosphonic acids as s1p receptor modulators
05/24/2012US20120129813 Novel compounds as receptor modulators with therapeutic utility
05/24/2012US20120129811 Tricyclic inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129807 Methods of treatment, improvement and prevention using haloaryl substituted aminopurines
05/24/2012US20120129785 Companion animal nutrition system
05/24/2012US20120129779 Tubulysine derivatives
05/24/2012US20120129778 Ligand that bind tgf-beta receptor rii
05/24/2012US20120129776 Bioactive peptides and method of using same
05/24/2012US20120129775 Antiangiogenic small molecules and methods of use
05/24/2012US20120129767 Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
05/24/2012US20120129761 Preparation of bone cement compositions
05/24/2012US20120129134 Light-Curable Bone Growth Material for Treating Dental Bone Defects
05/24/2012US20120128780 Nanoparticulate bisphosphonate compositions
05/24/2012US20120128774 Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
05/24/2012US20120128768 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
05/24/2012US20120128741 Modified hyaluronic acid polymer compositions and related methods
05/24/2012US20120128737 Compositions for treating degenerative joint diseases
05/24/2012US20120128699 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
05/24/2012US20120128693 Cadherin-11 inhibitors and methods of use thereof
05/24/2012US20120128689 Anti-il-23 immunoglobulins
05/24/2012US20120128686 Thienopyrimidines for pharmaceutical compositions
05/24/2012US20120128674 C3b antibodies and methods for the prevention and treatment of complement-associated disorders
05/24/2012US20120128668 Method of promoting bone growth by an anti-activin antibody
05/24/2012US20120128640 Heterocyclic compounds and expansion agents for hematopoietic stem cells
05/24/2012US20120128636 Gingiva Derived Stem Cell And Its Application In Immunodulation And Reconstruction
05/24/2012US20120128631 Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
05/24/2012US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof
05/24/2012US20120128597 Composition for prevention and treatment of allergic and/or inflammatory diseases
05/24/2012CA2818166A1 Keratin compositions for treatment of bone deficiency or injury
05/24/2012CA2817785A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
05/24/2012CA2817388A1 Quinolinone derivatives
05/23/2012EP2455372A1 Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecaboxylic acid by poor-solvent addition method
05/23/2012EP2455096A1 Oxidized protein hydrolase activity enhancer
05/23/2012EP2455079A2 Composition for the prevention or treatment of bone diseases comprising colforsin daropate
05/23/2012EP2454265A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
05/23/2012EP2453887A1 Use of pro-inflammatory compounds for promoting bone formation
05/23/2012EP2453886A2 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
05/23/2012EP2046797B1 Furo [3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 820